Schumer calls on VA to explain use of unproven drug on vets

The Senate's top Democrat on Sunday called on the Department of Veterans Affairs to explain why it allowed the use of an unproven drug on veterans for the coronavirus, saying patients may have been put at unnecessary risk.

Senator Charles Schumer of New York said the VA needs to provide Congress more information about a recent bulk order for $208,000 worth of hydroxychloroquine.

President Donald Trump has heavily promoted the malaria drug, without evidence, as a treatment for COVID-19.

Schumer's request comes after a whistleblower complaint filed this past week by former Health and Human Services official Rick Bright alleged that the Trump administration, eager for a quick fix to the onslaught of the coronavirus, wanted to flood hot spots in New York and New Jersey with the drug.

Major veterans organizations have urged VA to explain under what circumstances VA doctors initiate discussion of hydroxychloroquine with veterans as a treatment option.

There are concerns that they are using this drug when the medical evidence says it doesn't help and could hurt, Schumer said in an interview with The Associated Press.

He said given the fact the malaria drug, despite being untested, had been repeatedly pushed publicly by Trump, VA Secretary Robert Wilkie must address whether anyone at the department was pressured by the White House or the administration to use hydroxychloroquine for COVID-19.

Schumer said Wilkie also should answer questions about a recent analysis of VA hospital data that showed there were more deaths among patients given hydroxychloroquine versus standard care, including how much patients knew about the drug's risks before taking it.

In a statement Sunday, VA spokeswoman Christina Noel called it preposterous for anyone to suggest that VA would make treatment decisions based on anything other than "the best medical interests of patients."